TERAZOSIN HYDROCHLORIDE — all Canadian products
12 DINs
0 marketed/approved
0 in shortage
Every Health Canada Drug Identification Number whose active ingredient is TERAZOSIN HYDROCHLORIDE, with holder, form, strength and current status, compared weekly against the Drug Product Database.
| DIN | Product | Company | Form | Route | Strength | Status | Shortage |
|---|---|---|---|---|---|---|---|
| 00818658 | HYTRIN | BGP PHARMA ULC | Tablet | Oral | TERAZOSIN HYDROCHLORIDE 1 MG | Cancelled Post Market | |
| 00818666 | HYTRIN | BGP PHARMA ULC | Tablet | Oral | TERAZOSIN HYDROCHLORIDE 5 MG | Cancelled Post Market | |
| 00818674 | HYTRIN | BGP PHARMA ULC | Tablet | Oral | TERAZOSIN HYDROCHLORIDE 10 MG | Cancelled Post Market | |
| 00818682 | HYTRIN | BGP PHARMA ULC | Tablet | Oral | TERAZOSIN HYDROCHLORIDE 2 MG | Cancelled Post Market | |
| 02396319 | MYLAN-TERAZOSIN | MYLAN PHARMACEUTICALS ULC | Tablet | Oral | TERAZOSIN HYDROCHLORIDE 10 MG | Cancelled Post Market | |
| 02396289 | MYLAN-TERAZOSIN | MYLAN PHARMACEUTICALS ULC | Tablet | Oral | TERAZOSIN HYDROCHLORIDE 1 MG | Cancelled Post Market | |
| 02396297 | MYLAN-TERAZOSIN | MYLAN PHARMACEUTICALS ULC | Tablet | Oral | TERAZOSIN HYDROCHLORIDE 2 MG | Cancelled Post Market | |
| 02396300 | MYLAN-TERAZOSIN | MYLAN PHARMACEUTICALS ULC | Tablet | Oral | TERAZOSIN HYDROCHLORIDE 5 MG | Cancelled Post Market | |
| 02218984 | RATIO-TERAZOSIN - TAB 10MG | RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED | Tablet | Oral | TERAZOSIN HYDROCHLORIDE 10 MG | Cancelled Post Market | |
| 02218941 | RATIO-TERAZOSIN - TAB 1MG | RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED | Tablet | Oral | TERAZOSIN HYDROCHLORIDE 1 MG | Cancelled Post Market | |
| 02218968 | RATIO-TERAZOSIN - TAB 2MG | RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED | Tablet | Oral | TERAZOSIN HYDROCHLORIDE 2 MG | Cancelled Post Market | |
| 02218976 | RATIO-TERAZOSIN - TAB 5MG | RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED | Tablet | Oral | TERAZOSIN HYDROCHLORIDE 5 MG | Cancelled Post Market |
Browse other molecules: